Provention Bio (PRVB) Key Ratios

$24.98

$0.00 (0.00%)

As on 27-Apr-2023 09:30EDT

Market cap

info icon

$2,375 Mln

Revenue (TTM)

info icon

$13 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1,330.29 1,408.09 824.37 -- --
EBIT -38.14 -55.53 -11.03 -198.68 -264.47
Net Profit -18.05 -28.84 1.27 -184.81 -259.65
EPS -30.65 -8.23 13.05 -16.66 -16.18
Book Value -- -- -- -- -6.21
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info -4,639.52-4,639.52-993.88-8,285.16--
Net Margin info -12,167.54-11,496.91---7,425.83-16,909.26
Return on equity info 86.32125.51133.4348.7276.81
Return on Capital info 93.91130.07155.8648.8677.02
Return on Assets info -79.84-71.96-60.98-86.64-91.91
Debt to Equity (x) info ----0.200.000.00
ROCE

155.86

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
155.86
48.86
77.02
434.96
-66.35
Peer Median
--
--
--
--
--
ROE

133.43

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
133.43
48.72
76.81
434.96
-66.35
Peer Median
--
--
--
--
--
ROA

-60.98

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-60.98
-86.64
-91.91
-57.21
-63.07
Peer Median
--
--
--
--
--
EBIT Margin

-993.88

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-993.88
-8,285.16
--
--
--
Peer Median
--
--
--
--
--
Net Margin

-880.69

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-880.69
-7,425.83
-16,909.26
-3,882.06
-17,770.47
Peer Median
--
--
--
--
--
Revenue Growth

8.24

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
8.24
--
--
--
--
Peer Median
--
--
--
--
--
EBIT Growth

-10.89

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-10.89
-15.94
-124.66
-66.41
-191.95
Peer Median
--
--
--
--
--
Net Profit Growth

0.76

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
0.76
-16.08
-133.62
-59.37
-189.91
Peer Median
--
--
--
--
--
EPS Growth

0.17

--

Year on year growth in earnings per share

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
0.17
0.04
-0.84
0.14
-0.19
Peer Median
--
--
--
--
--
Debt to Equity

0.20

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
0.20
0.00
0.00
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.93

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
1.93
4.44
7.56
22.39
32.89
Peer Median
--
--
--
--
--
Quick Ratio

1.92

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
1.92
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

-123.59

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-123.59
-791.63
-161.83
--
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.54

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
10.54
--
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

0.07

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
0.07
0.01
--
--
--
Peer Median
--
--
--
--
--
Receivable days

38.49

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
38.49
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

878.17

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
878.17
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

3,676.40

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
3,676.40
--
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-2,759.74

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-2,759.74
--
--
--
--
Peer Median
--
--
--
--
--
Price / Earnings

-6.98

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-6.98
-3.09
-8.94
-14.48
-1.47
Peer Median
--
--
--
--
--
Price / Book Value

6.51

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
6.51
-1.21
-4.96
-7.73
0.65
Peer Median
--
--
--
--
--
EV/EBITDA

-5.23

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Provention Bio (PRVB)
-5.23
-2.26
-7.62
--
0.74
Peer Median
--
--
--
--
--
loading...
loading...